Biological evaluation of combinations of tyrosine kinase inhibitors with Inecalcitol as novel treatments for human chronic myeloid leukemia.

Autor: Al-Ali L; Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan., Al-Ani RJ; Department of Anaesthesia, Faculty of Allied Medical Sciences, Isra University, Amman 11622, Jordan., Saleh MM; Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan., Hammad AM; Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, Jordan., Abuarqoub DA; Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman 11196, Jordan.; Cell Therapy Center, University of Jordan, Amman 11942, Jordan., Abu-Irmaileh B; Hamdi Mango Center for Scientific Research, University of Jordan, Amman 11942, Jordan., Naser AY; Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan., Najdawi MM; Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan., Abbas MM; Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.; Pharmacological and Diagnostic Research Laboratory, Al-Ahliyya Amman University, Amman 19328, Jordan., Alyoussef Alkrad J; Department of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.

Publikováno v: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2024 Feb; Vol. 32 (2), pp. 101931. Date of Electronic Publication: 2023 Dec 20.